New leukaemia drug has given hope to patients as it kills nearly 90 per cent of their cancer in the first dose. Gazyva, which so powerful it can send patients into shock, comes with a whopping 42,000 dollar bill, News.com.au reported. Though the drug has been approved for use in Australia but not yet subsidised by the Pharmaceutical Benefits Scheme and has some serious side effects including increased risk of infections, including lower white blood ...
Read More
You have just read an article categorized health
titled New Leukaemia Drug Kills 90pc of Cancer in First Dose.
Written by:
editor -
Monday, October 27, 2014
There are currently no comments for "New Leukaemia Drug Kills 90pc of Cancer in First Dose"
Post a Comment